Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Prepaid Assets: 2016-2024

Historic Prepaid Assets for UroGen Pharma (URGN) over the last 9 years, with Dec 2024 value amounting to $8.8 million.

  • UroGen Pharma's Prepaid Assets fell 13.74% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year decrease of 13.74%. This contributed to the annual value of $8.8 million for FY2024, which is 13.97% down from last year.
  • Latest data reveals that UroGen Pharma reported Prepaid Assets of $8.8 million as of FY2024, which was down 13.97% from $10.3 million recorded in FY2023.
  • In the past 5 years, UroGen Pharma's Prepaid Assets ranged from a high of $11.1 million in FY2022 and a low of $3.4 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $10.3 million (2023), whereas its average is $10.1 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 225.34% in 2020, then fell by 13.97% in 2024.
  • Yearly analysis of 5 years shows UroGen Pharma's Prepaid Assets stood at $3.4 million in 2020, then soared by 122.24% to $7.5 million in 2021, then skyrocketed by 48.49% to $11.1 million in 2022, then dropped by 7.39% to $10.3 million in 2023, then decreased by 13.97% to $8.8 million in 2024.